News
12 May 2026
Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
10 July 2026
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
Global CRO highlights multi-regional trial delivery, early-phase Australia advantages, and expanding support for biotech sponsors across Asia and China.
19 May 2026
Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026
Avance Clinical will engage with biotech sponsors to discuss strategies for delivering efficient, high-quality oncology trials spanning first-in-human through to later-phase proof of concept global programs.
15 April 2025
Avance Clinical to Showcase Asia-Pacific Clinical Trial Expertise at BIO KOREA 2025
Avance Clinical will attend BIO Korea 2025 to meet with biotechs and share clinical trial capabilities across the region including Australia, New Zealand, South Korea, Taiwan, North America and beyond.
3 May 2024
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend World Vaccine Congress in Washington DC (April 1-4, 2024) and share the latest clinical trial client news including the Uvax Bio announcement. (Booth #267)
14 September 2023
Join Avance Clinical In Seoul At KoNECT Korea 2023
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will visit Seoul in October to expand on collaborative opportunities with South Korean biotech companies.
30 May 2023
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients
Avance Clinical the leading award-winning Australian and North American CRO that offers ClinicReady and GlobalReady for early-phase biotech companies to speed up the path to regulatory approval, says early-phase oncology studies are increasingly more complex and demand more patients.
18 April 2023
Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023
Avance Clinical the leading award-winning Australian and North American biotech CRO that offers a GlobalReady program to early-phase biotech companies to speed up the path to regulatory approval, has been invited to join the Evolution Europe Summit 2023
9 June 2022
Avance Clinical Announces at BIO 2022: Expansion Across Australia and New Zealand – New Offices and Double Growth
Avance Clinical, the largest premium Australian Contract Research Organization (CRO) for international biotechs, has opened new offices in Sydney and Melbourne, with further expansions planned, and increased clinical staff numbers across the region to support double growth figures.
Proven industry
experience & expertise
500+
Studies in the past 5 years
450+
Experienced team members
18k+
Participants past 5 years
30
Years of CRO experience